How Many Operators Are Optimal for Higher-Risk Percutaneous Coronary Intervention Procedures?
作者信息
Lee Jinhyun, Moses Jeffrey W, Kirtane Ajay J
机构信息
Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation New York NY.
出版信息
J Am Heart Assoc. 2021 Dec 7;10(23):e023567. doi: 10.1161/JAHA.121.023567. Epub 2021 Nov 15.
Abstract
摘要
相似文献
1
How Many Operators Are Optimal for Higher-Risk Percutaneous Coronary Intervention Procedures?对于高风险经皮冠状动脉介入手术，多少操作人员最为合适？
J Am Heart Assoc. 2021 Dec 7;10(23):e023567. doi: 10.1161/JAHA.121.023567. Epub 2021 Nov 15.
2
Are Higher Operator Volumes for Unprotected Left Main Stem Percutaneous Coronary Intervention Associated With Improved Patient Outcomes?: A Survival Analysis of 6724 Procedures From the British Cardiovascular Intervention Society National Database.更高的无保护左主干经皮冠状动脉介入术（ULMCA）手术量与改善患者预后相关吗？：来自英国心血管介入学会国家数据库的 6724 例手术的生存分析。
Circ Cardiovasc Interv. 2020 Jun;13(6):e008782. doi: 10.1161/CIRCINTERVENTIONS.119.008782.
3
When high-volume PCI operators in high-volume hospitals move to lower volume hospitals-Do they still maintain high volume and quality of outcomes?当高容量医院的高容量 PCI 操作人员转移到低容量医院时，他们是否仍然保持高容量和高质量的结果？
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):644-650. doi: 10.1002/ccd.27403. Epub 2017 Oct 31.
4
Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR.经皮冠状动脉介入治疗后风险标准化死亡率的操作人员变异性评估：来自 NCDR 的报告。
JACC Cardiovasc Interv. 2017 Apr 10;10(7):672-682. doi: 10.1016/j.jcin.2016.12.019.
5
Association of Operator and Hospital Experience With Procedural Success Rates and Outcomes in Patients Undergoing Percutaneous Coronary Interventions for Chronic Total Occlusions: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.在接受经皮冠状动脉介入治疗慢性完全闭塞病变的患者中，术者经验与医院经验与手术成功率及预后的关联：来自密歇根蓝十字蓝盾心血管联盟的见解
Circ Cardiovasc Interv. 2020 Aug;13(8):e008863. doi: 10.1161/CIRCINTERVENTIONS.119.008863. Epub 2020 Aug 14.
6
Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009).年度术者和机构手术量对经皮冠状动脉介入治疗结局的影响：美国 5 年经验（2005-2009 年）。
Circulation. 2014 Oct 14;130(16):1392-406. doi: 10.1161/CIRCULATIONAHA.114.009281. Epub 2014 Sep 4.
7
Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013.2001 - 2013年台湾未达经皮冠状动脉介入治疗最低手术量标准的医院及医疗机构比例变化趋势。
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):247-250. doi: 10.1002/ccd.27343. Epub 2017 Sep 30.
8
Middle-of-the-night percutaneous coronary intervention and its association with percutaneous coronary intervention outcomes performed the following day: an analysis from the National Cardiovascular Data Registry.半夜行经皮冠状动脉介入治疗及其与次日行经皮冠状动脉介入治疗结果的关系：来自全国心血管数据注册中心的分析。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):49-56. doi: 10.1016/j.jcin.2014.08.010.
9
Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India-Kerala Primary Percutaneous Coronary Intervention Registry.印度喀拉拉邦 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的操作量与结局：印度心脏病学会-喀拉拉邦直接经皮冠状动脉介入治疗注册研究报告。
J Am Heart Assoc. 2020 Jun 16;9(12):e014968. doi: 10.1161/JAHA.119.014968. Epub 2020 Jun 1.
10
Impact of Institutional and Operator Volume on Short-Term Outcomes of Percutaneous Coronary Intervention: A Report From the Japanese Nationwide Registry.机构和术者量对经皮冠状动脉介入治疗短期结局的影响：来自日本全国登记的报告。
JACC Cardiovasc Interv. 2017 May 8;10(9):918-927. doi: 10.1016/j.jcin.2017.02.015.
引用本文的文献
1
Complex high-risk indicated PCI (CHIP-PCI): is it safe to let fellows-in-training perform it as primary operators?复杂高危指征性经皮冠状动脉介入治疗（CHIP-PCI）：让培训学员作为主要术者进行该操作是否安全？
Open Heart. 2025 Jan 30;12(1):e003131. doi: 10.1136/openhrt-2024-003131.
2
Single versus Dual-Operator Approaches for Percutaneous Coronary Interventions within Chronic Total Occlusion-An Analysis of 27,788 Patients.慢性完全闭塞病变经皮冠状动脉介入治疗的单操作者与双操作者方法——27788例患者的分析
J Clin Med. 2023 Jul 14;12(14):4684. doi: 10.3390/jcm12144684.
本文引用的文献
1
Clinical Characteristics and Outcomes Among Patients Undergoing High-Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.接受单名或多名术者行高危经皮冠状动脉介入治疗的患者的临床特征和结局：来自退伍军人事务部临床评估、报告和跟踪计划的见解。
J Am Heart Assoc. 2021 Dec 7;10(23):e022131. doi: 10.1161/JAHA.121.022131. Epub 2021 Nov 15.
2
Prevalence, Trends, and Outcomes of Higher-Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes.非急性冠状动脉综合征患者中高风险经皮冠状动脉介入治疗的患病率、趋势及结局
Cardiovasc Revasc Med. 2019 Apr;20(4):289-292. doi: 10.1016/j.carrev.2018.07.017. Epub 2018 Jul 20.
3
Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty.经皮冠状动脉慢性完全闭塞病变介入治疗围术期并发症的发生率、预测因素及其对健康状况的影响。
EuroIntervention. 2018 Dec 7;14(11):e1199-e1206. doi: 10.4244/EIJ-D-17-00976.
4
Surgeon Involvement in Transcatheter Aortic Valve Replacement in the United States: A 2016 Society of Thoracic Surgeons Survey.美国外科医生参与经导管主动脉瓣置换术：2016年胸外科医师协会调查
Ann Thorac Surg. 2017 Sep;104(3):1088-1093. doi: 10.1016/j.athoracsur.2017.03.055. Epub 2017 Apr 10.
5
Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention.术者经验和手术量对左主干经皮冠状动脉介入治疗结局的影响。
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2086-2093. doi: 10.1016/j.jcin.2016.08.011.
6
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.有血运重建指征的高危患者的治疗：当代经皮冠状动脉介入治疗领域的进展
Circulation. 2016 Aug 2;134(5):422-31. doi: 10.1161/CIRCULATIONAHA.116.022061.
7
Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions: Characteristics, Success, and Outcomes.经皮冠状动脉介入治疗的慢性完全闭塞患者：特征、成功率和结局。
Circ Cardiovasc Interv. 2016 May;9(5):e003586. doi: 10.1161/CIRCINTERVENTIONS.116.003586.
Zotero 插件